Milestone Scientific Inc. (MLSS) is a Healthcare stock trading at $0.46 (as of 2026-08-20), with a market capitalization of $41.12M. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.
Milestone Scientific Inc. designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates in two segments, Dental and Medical. Its products include CompuDent and STA Single Tooth Anesthesia System that are used for all dental procedures that require local anesthetic. The company also offers CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances; and disposable injection handpiece for the tactile control during the injection. In addition, it provides CompuFlo Epidural, a computer controlled anesthesia system for use in various medical applications. Further, the company offers CompuMed for use in various medical procedures performed in plastic, hair restoration, and colorectal surgery, as well as podiatry, dermatology, orthopedics, and various other disciplines. Milestone Scientific Inc. was incorporated in 1989 and is headquartered in Livingston, New Jersey.
Milestone Scientific Inc. designs and commercializes injection technologies and devices, including dental anesthesia systems and a computer-controlled drug delivery system, and earns money by selling these products to medical, dental, and cosmetic users in the United States, China, and internationally.
Its profit model depends on clinical adoption of its injection technology platforms (Dental and Medical), because its revenue is tied to ongoing use of its systems in medical and dental procedures.
Business quality (Weak): The company has established product lines across Dental and Medical, but the provided latest-quarter data shows a negative operating margin, suggesting operating expenses are not currently supported by the scale implied by revenue in the dataset.
| Price | $0.46 |
| Market Cap | $41.12M |
| Price / Book | 11.85 |
| Price / Sales | 4.32 |
| FCF Yield | -7.4% |
| Revenue (TTM) | $8.97M |
| Net Margin | -63.8% |
| Revenue Growth (YoY) | 4.0% |
| EPS Growth (YoY) | 16.7% |
| FCF Growth (YoY) | 0.1% |
| Altman Z-Score | -20.26 (distress) |
| Sector P/E (Healthcare) | 21.6 |
| Industry P/E (Medical Equipment) | 32.9 |
| Top Institutional Holder | VANGUARD GROUP INC ($641364.00) |
| Institutional Holders Tracked | 10 |
| Sector | Healthcare |
| Industry | Medical Equipment |
| CEO | Eric C. Hines |
| Employees | 17 |
| Country | US |
| IPO Date | 1995-11-03 |
Data as of 2026-08-20.
Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.